Shang Xiushuai, Wang Zhaofei, Tao Hairong
Department of Orthopedic Surgery, Shanghai Key Laboratory of Orthopedic Implant, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Ther Clin Risk Manag. 2017 Aug 1;13:951-956. doi: 10.2147/TCRM.S139814. eCollection 2017.
Osteoarthritis (OA) is the most common form of articular joint arthritis and a cause of significant morbidity. In this review, we present the role of nerve growth factor (NGF) in pain generation, relationship between NGF and OA pain, and pathogenic factors (interleukin-1β, transforming growth factor-β1, mechanical loading, and adipokines) involved in OA development. Since NGF blocking is an efficient way to inhibit OA-associated pain, we summarize four categories of drugs that target NGF/tropomyosin receptor kinase A (TrkA) signaling. In addition, we discuss the future of NGF/TrkA antagonists and underline their potential for use in OA pain relief. A better understanding of the causes and treatment of OA will facilitate the development of more effective methods of OA pain management.
骨关节炎(OA)是最常见的关节性关节炎形式,也是导致严重发病的原因。在本综述中,我们阐述了神经生长因子(NGF)在疼痛产生中的作用、NGF与OA疼痛之间的关系,以及参与OA发展的致病因素(白细胞介素-1β、转化生长因子-β1、机械负荷和脂肪因子)。由于阻断NGF是抑制OA相关疼痛的有效方法,我们总结了四类靶向NGF/原肌球蛋白受体激酶A(TrkA)信号传导的药物。此外,我们讨论了NGF/TrkA拮抗剂的未来,并强调了它们在缓解OA疼痛方面的潜力。更好地理解OA的病因和治疗方法将有助于开发更有效的OA疼痛管理方法。